Skip to content
  • Sunday, 26 July 2026
  • 3:39 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study

Rifan Muazin Jun 4, 2026 0

A pharmaceutical combination that has become a cornerstone of modern anti-aging and longevity research may pose a severe risk to…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study

Rifan Muazin May 27, 2026 0

A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…

Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial.Building Modern EDA Pipelines with Pingouin: Enhancing Data Quality for Robust Machine Learning ModelsMIT Researchers Develop Breakthrough Terahertz Microscope to Visualize Quantum Vibrations in Superconducting MaterialsEvogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ